Commentary|Podcasts|February 9, 2024
Episode 108: Advancing the Genetic Pool of Parkinson Disease
Author(s)Marco Meglio
Mind Moments®, a podcast from NeurologyLive®, brings you an interview with Ignacio Mata, PhD. [LISTEN TIME: 21 minutes]
Advertisement
Episode 108 of the NeurologyLive® Mind Moments ® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 108, "Advancing the Genetic Pool of Parkinson Disease" features a conversation with Igancio Mata, PhD, who sat down to discuss a recently published meta-analysis on the genetic backgrounds of Parkinson disease beyond traditional European populations. Mata, an associate professor in the Genomic Medicine Institute at Cleveland Clinic, provided insight on the newly identified novel loci and how the data adds to previous genome-wide association studies. In addition, he gave thoughts on the possibility of gene therapy and some of the barriers that come with it, as well as the feasibility of incorporating genetic checkpoints into clinical trial inclusion criteria.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Biogen Walks Away From Aducanumab to Prioritize Lecanemab and Alzheimer Disease Pipeline Updated Guidelines Published to Improve Care in Specialized Epilepsy Centers FDA Clears IND for Gene Therapy Candidate ETX101 in Dravet Syndrome
This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com
EPISODE BREAKDOWN
- 1:10 – Meta-analysis overview
- 3:20 – Significance of results, how they add to the literature
- 6:50 – Feasibility of incorporating genetic screening into clinical trials
- 8:40 – Neurology News Minute
- 11:15 – Realistic expectations and potential with gene therapy
- 15:45 – Next steps in advancing this research
Hoping to listen on your favorite podcast app? See below:
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
NeurologyLive® Friday 5 — September 12, 2025
5